Log in to save to my catalogue

Liver damage in bleomycin-induced pulmonary fibrosis in mice

Liver damage in bleomycin-induced pulmonary fibrosis in mice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2258485142

Liver damage in bleomycin-induced pulmonary fibrosis in mice

About this item

Full title

Liver damage in bleomycin-induced pulmonary fibrosis in mice

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Naunyn-Schmiedeberg's archives of pharmacology, 2019-12, Vol.392 (12), p.1503-1513

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Pulmonary fibrosis is an emerging disease with a poor prognosis and high mortality rate that is even surpassing some types of cancer. This disease has been linked to the concomitant appearance of liver cirrhosis. Bleomycin-induced pulmonary fibrosis is a widely used mouse model that mimics the histopathological and biochemical features of human sys...

Alternative Titles

Full title

Liver damage in bleomycin-induced pulmonary fibrosis in mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2258485142

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2258485142

Other Identifiers

ISSN

0028-1298

E-ISSN

1432-1912

DOI

10.1007/s00210-019-01690-7

How to access this item